Here are relevant reports on : hematology-reagents-market
-
COVID 19 Impact on IVD (In Vitro Diagnostics) Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region - Global Forecast to 2025
The COVID 19 Impact on IVD (In Vitro Diagnostics) Market is expected to grow from USD 61.7 billion in 2020 to USD 77.9 billion by 2025, at a CAGR of 4.8% during the forecast period. As of 2019, some of the prominent players in the in-vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France), and QIAGEN (Germany), among others.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031
The Europe companion animal diagnostics market, valued at US$0.43 billion in 2025, stood at US$0.46 billion in 2026 and is projected to advance at a resilient CAGR of 8.6% from 2026 to 2031, culminating in a forecasted valuation of US$0.70 billion by the end of the period. The market for diagnostics of companion animals in Europe is experiencing fast growth owing to factors such as increased pet ownership, animal health awareness, and advanced veterinary care being more widely accepted and costly.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Europe in vitro diagnostics (IVD) market, valued at USD 31.43 billion in 2025, stood at USD 33.83 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of USD 49.49 billion by the end of the period. Market growth is driven by rising diagnostic test volumes across national healthcare systems, broader adoption of population-based screening programs, and increasing emphasis on standardized disease monitoring.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Life Sciences & Analytical Reagents Market - Applications, Current Trends, Opportunities & Global Forecasts (2011 – 2016)
The life sciences and analytical reagents market report studies the life science and analytical reagents market, by technology, end-users, and applications. The life sciences and analytical reagents market, by technology studied in this report are segmented as life science reagents and analytical reagents; of which life science segment accounted for the largest share of 59.37% of the total market in 2011.
- Published: May 2012
- Price: $ 4950
- TOC Available:
-
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) & Geography - Global Forecast to 2022
The clinical laboratory services market is expected to reach USD 146.41 billion by 2022 from USD 113.4 billion in 2017, at a CAGR of 5.2% during the forecast period. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
- Published: December 2017
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028
The global plasma fractionation market, valued at US$27.2 billion in 2022, stood at US$29.0 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2025 to 2028, culminating in a forecasted valuation of US$40.4 billion by the end of the period. Market growth is driven mainly by factors such as the growing use of immunoglobulins in various therapeutic areas, strategic expansion of plasma collection centers/inventories by market players, and the growing prevalence of respiratory diseases and AATD
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Immunotherapy Drugs Market by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
The global immunotherapy drugs market, valued at US$255.9 billion in 2023, stood at US$285.3 billion in 2024 and is projected to advance at a resilient CAGR of 15.3% from 2024 to 2029, culminating in a forecasted valuation of US$580.6 billion by the end of the period. This growth is driven by technological advancements in antibody engineering, increasing demand for antibody therapies in clinical cancer treatment, and a growing preference for personalized medicines and targeted therapies.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Hematology), Application (Clinical Pathology, Virology), Animal (Dogs, Cats, Horses), End User (Diagnostic Laboratories) - Global Forecast to 2029
The global companion animal diagnostics market, valued at US$2.75 billion in 2023, stood at US$2.99 billion in 2024 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2029, culminating in a forecasted valuation of US$4.55 billion by the end of the period. The growing demand for rapid tests and portable instruments for point-of-care (POC) services is offering growth opportunities for players in the companion animal diagnostics market.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
The latin american flow cytometry market size is projected to reach USD 379 million by 2027, at a CAGR of 7.1% during the forecast period. Key players in this market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Cytek Biosciences, Inc. (US), and Luminex Corporation (US).
- Published: November 2022
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
